Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Morgan Stanley stock logo
MS
Morgan Stanley
$111.49
-2.2%
$131.51
$85.01
$142.03
$179.81B1.356.28 million shs7.43 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.60
-0.4%
$26.26
$24.48
$31.54
$145.08B0.6140.06 million shs36.67 million shs
Vale S.A. stock logo
VALE
Vale
$9.42
+1.6%
$9.29
$8.38
$13.14
$42.08B0.8535.46 million shs24.07 million shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Morgan Stanley stock logo
MS
Morgan Stanley
-2.19%-6.33%-19.09%-12.49%+24.75%
Pfizer Inc. stock logo
PFE
Pfizer
-0.49%-2.31%+0.26%+0.07%-9.24%
Vale S.A. stock logo
VALE
Vale
+1.62%-3.89%-1.67%+1.84%-23.36%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Morgan Stanley stock logo
MS
Morgan Stanley
4.7644 of 5 stars
3.23.04.22.42.12.52.5
Pfizer Inc. stock logo
PFE
Pfizer
4.9719 of 5 stars
3.33.04.24.22.83.33.1
Vale S.A. stock logo
VALE
Vale
4.5499 of 5 stars
3.25.03.30.03.30.03.8
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Morgan Stanley stock logo
MS
Morgan Stanley
2.35
Hold$131.2717.74% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.59
Moderate Buy$31.9224.70% Upside
Vale S.A. stock logo
VALE
Vale
2.30
Hold$13.2640.80% Upside

Current Analyst Ratings Breakdown

Latest MS, PFE, and VALE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/12/2025
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/10/2025
Pfizer Inc. stock logo
PFE
Pfizer
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
2/10/2025
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$33.00 ➝ $33.00
1/28/2025
Pfizer Inc. stock logo
PFE
Pfizer
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$30.00 ➝ $29.00
1/21/2025
Morgan Stanley stock logo
MS
Morgan Stanley
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$130.00 ➝ $140.00
1/17/2025
Morgan Stanley stock logo
MS
Morgan Stanley
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$155.00 ➝ $156.00
1/17/2025
Morgan Stanley stock logo
MS
Morgan Stanley
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$146.00 ➝ $153.00
1/17/2025
Morgan Stanley stock logo
MS
Morgan Stanley
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$140.00 ➝ $150.00
1/17/2025
Morgan Stanley stock logo
MS
Morgan Stanley
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Perform ➝ Market Perform$138.00 ➝ $145.00
1/13/2025
Morgan Stanley stock logo
MS
Morgan Stanley
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$104.00 ➝ $108.00
1/8/2025
Pfizer Inc. stock logo
PFE
Pfizer
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$31.00 ➝ $29.00
(Data available from 3/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Morgan Stanley stock logo
MS
Morgan Stanley
$57.62B3.12$6.98 per share15.97$55.58 per share2.01
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.28$4.01 per share6.38$15.81 per share1.62
Vale S.A. stock logo
VALE
Vale
$38.06B1.12$2.26 per share4.17$9.03 per share1.04
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Morgan Stanley stock logo
MS
Morgan Stanley
$13.39B$7.9414.0411.821.1812.48%14.39%1.09%4/15/2025 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.4118.168.450.6412.62%19.47%8.09%4/29/2025 (Estimated)
Vale S.A. stock logo
VALE
Vale
$7.98B$1.446.544.460.3116.15%17.38%7.62%4/23/2025 (Estimated)

Latest MS, PFE, and VALE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/19/2025Q4 2024
Vale S.A. stock logo
VALE
Vale
$0.56$0.20-$0.36$0.56$10.03 billion$10.12 billion
2/4/2025Q4 2024
Pfizer Inc. stock logo
PFE
Pfizer
$0.48$0.63+$0.15$0.07$17.26 billion$17.76 billion
1/16/2025Q4 24
Morgan Stanley stock logo
MS
Morgan Stanley
$1.54$2.22+$0.68$2.22$15.03 billion$16.23 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Morgan Stanley stock logo
MS
Morgan Stanley
$3.703.32%+19.13%46.60%12 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.72%+2.50%121.99%16 Years
Vale S.A. stock logo
VALE
Vale
$0.757.97%N/A52.08%N/A

Latest MS, PFE, and VALE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/20/2025
Vale S.A. stock logo
VALE
Vale
semi-annual$0.37587.5%3/10/20253/10/20253/21/2025
1/16/2025
Morgan Stanley stock logo
MS
Morgan Stanley
quarterly$0.92502.82%1/31/20251/31/20252/14/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Morgan Stanley stock logo
MS
Morgan Stanley
3.14
0.80
0.80
Pfizer Inc. stock logo
PFE
Pfizer
0.63
1.00
0.73
Vale S.A. stock logo
VALE
Vale
0.39
0.91
0.58

Institutional Ownership

CompanyInstitutional Ownership
Morgan Stanley stock logo
MS
Morgan Stanley
84.19%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Vale S.A. stock logo
VALE
Vale
21.85%

Insider Ownership

CompanyInsider Ownership
Morgan Stanley stock logo
MS
Morgan Stanley
0.24%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
Vale S.A. stock logo
VALE
Vale
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Morgan Stanley stock logo
MS
Morgan Stanley
80,0001.61 billion1.61 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.67 billion5.66 billionOptionable
Vale S.A. stock logo
VALE
Vale
66,8074.54 billion4.54 billionOptionable

Recent News About These Companies

Vale S.A. Achieves Key Milestone in Salobo III Project
Vale S.A. Submits Compliance Report to SEC
Vale S.A. Submits Compliance Report to SEC
Vale S.A. Files SEC Report as Foreign Private Issuer
Vale S.A. Submits SEC Report for March 2025
Vale S.A. Submits Compliance Report to SEC
StockTake: Iron Bear comes alive under Vale

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Morgan Stanley stock logo

Morgan Stanley NYSE:MS

$111.49 -2.51 (-2.21%)
Closing price 03/13/2025 03:59 PM Eastern
Extended Trading
$112.34 +0.85 (+0.77%)
As of 08:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments. The Institutional Securities segment offers capital raising and financial advisory services, including services related to the underwriting of debt, equity, and other securities, as well as advice on mergers and acquisitions, restructurings, real estate, and project finance. This segment also provides equity and fixed income products comprising sales, financing, prime brokerage, and market-making services; foreign exchange and commodities; corporate and commercial real estate loans, commercial mortgage and secured lending facilities, and financing for sales and trading customers, and asset-backed and mortgage lending; and wealth management services, investment, and research services. The Wealth Management segment offers financial advisor-led brokerage, custody, administrative, and investment advisory services; self-directed brokerage services; financial and wealth planning services; workplace services, including stock plan administration; annuity and insurance products; securities-based lending, residential real estate loans, and other lending products; banking; and retirement plan services to individual investors and small to medium-sized businesses and institutions. The Investment Management segment provides equity, fixed income, alternatives and solutions, and liquidity and overlay services to benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds, insurance companies, third-party fund sponsors, corporations, and individuals through institutional and intermediary channels. The company was founded in 1924 and is headquartered in New York, New York.

Pfizer stock logo

Pfizer NYSE:PFE

$25.60 -0.11 (-0.43%)
Closing price 03/13/2025 03:59 PM Eastern
Extended Trading
$25.68 +0.09 (+0.34%)
As of 08:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Vale stock logo

Vale NYSE:VALE

$9.41 +0.15 (+1.56%)
Closing price 03/13/2025 03:59 PM Eastern
Extended Trading
$9.51 +0.10 (+1.01%)
As of 08:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Vale S.A., together with its subsidiaries, produces and sells iron ore and iron ore pellets for use as raw materials in steelmaking in Brazil and internationally. The company operates through Iron Solutions and Energy Transition Materials segments. The Iron Solutions segment produces and extracts iron ore and pellets, manganese, and other ferrous products; and provides related logistic services. The Energy Transition Materials segment produces and extracts nickel used to produce stainless steel, electric vehicles, and metal alloys; and its by-products, such as gold, silver, cobalt, precious metals, platinum, and others, as well as copper used in the construction sector to produce pipes and electrical wires. The company was formerly known as Companhia Vale do Rio Doce and changed its name to Vale S.A. in May 2009. Vale S.A. was founded in 1942 and is headquartered in Rio de Janeiro, Brazil.